Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally, then invited them to access ObvioGo™ to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
Efficacy was proven. Subjects reported the treatment had helped to reduced symptoms of LUTS.
Are you interested in learning more about ObvioHealth’s proprietary platform built to withstand today’s challenges?